OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Pulmonary Tuberculosis


As per available reports about 11Relevant journals,13Conferences,10Workshops are presently dedicated exclusively to breathing disorder and about 321 articles are being published on pulmonary tuberculosis.

Pulmonary tuberculosis (TB) is a contagious bacterial infection that involves the lungs. It grows best in areas of the body that have lots of blood and oxygen. That's why it is most often found in the lungs. This is called pulmonary TB. But TB can also spread to other parts of the body, which is called extra pulmonary TB. It may spread to other organs. The bacterium (germ) that causes TB is called Mycobacterium tuberculosis. This germ can cause other kinds of TB, but pulmonary TB is the most common. People who are most at risk for developing TB disease are the elderly, small children, smokers, people who already have an immune system problem, such as HIV, people who do not regularly see a doctor, such as homeless people, people who live in crowded conditions. The symptoms of tuberculosis are- loss of weight, loss of energy, poor appetite, fever, a productive cough, night sweats , breathlessness, extreme tiredness or fatigue and unexplained pain for more than three weeks.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide. 

Scope and Importance:

The prevalence of tuberculosis in adult men in India is 2–4 times higher than in women. Tobacco smoking is prevalent almost exclusively among men, so it is possible that tobacco smoking may be a risk factor for developing pulmonary tuberculosis. A nested case control study was carried out to study the association between tobacco smoking and pulmonary tuberculosis. Tuberculosis can cause chronic impairment of lung function which increases incrementally with the number of episodes of tuberculosis. Clearly, prevention of tuberculosis and its effect on lung function is important and can be achieved by early detection and by reduction of the risk of tuberculosis through intervention on risk factors such as HIV, silica dust exposure, silicosis, and socioeconomic factors. Hundreds of studies have evaluated the diagnostic accuracy of nucleic-acid amplification tests (NAATs) for tuberculosis (TB). Commercial tests have been shown to give more consistent results than in-house assays. Previous meta-analyses have found high specificity but low and highly variable estimates of sensitivity. However, reasons for variability in study results have not been adequately explored. We performed a meta-analysis on the accuracy of commercial NAATs to diagnose pulmonary TB and meta-regression to identify factors that are associated with higher accuracy.

Pulmonary tuberculosis (TB) is a contagious bacterial infection that involves the lungs. It grow best in areas of the body that have lots of blood and oxygen. That's why it is most often found in the lungs. This is called pulmonary TB. But TB can also spread to other parts of the body, which is called extrapulmonary TB. It may spread to other organs. The bacterium (germ) that causes TB is called Mycobacterium tuberculosis. This germ can cause other kinds of TB, but pulmonary TB is the most common. People who are most at risk for developing TB disease are the elderly, small children, smokers, people who already have an immune system problem, such as HIV, people who do not regularly see a doctor, such as homeless people, people who live in crowded conditions. The symptoms of tuberculosis are- loss of weight, loss of energy, poor appetite, fever, a productive cough, night sweats , breathlessness, extreme tiredness or fatigue and unexplained pain for more than three weeks. There are different tests for the diagnosis of tuberculosis which includes- Biopsy of the affected tissue, Bronchoscopy, Chest CT scan, Chest x-ray and Tuberculin skin test. Therapy for TB requires a minimum of 6 months of treatment except for culture-negative pulmonary TB. Treatment is initiated when TB is confirmed or strongly suspected and consists of an initial intensive phase and a subsequent continuation phase. Treatment of latent infection is usually with isoniazid for 9 months, or rifampicin for 4 months. If exogenous reinfection is suspected, TB treatment should be based on the drug susceptibility profile of the index case, if known. Pulmonary tuberculosis Conference provides the scope for opportunities to learn progressed by international scientists and academicians. Pulmonary tuberculosis Conference offers excessive quality content to suit the diverse development of medicines and technology to treat people all over the globe. Pulmonary tuberculosis conference is a perfect platform to discuss the current discoveries and developments in the field of Pulmonology. The National Symposium on Pulmonary Tuberculosis offers an opportunity for a diverse group of attendees to network, compare programs, learn about new approaches, and discuss the latest issues facing the development in the field of the treatment of Pulmonary Tuberculosis. The conference is a platform where doctors, clinicians, researchers, health policy makers, physicians, nurses and health professionals can interact and discuss the current and future scenario in the field of Pulmonary Tuberculosis.

Market Analysis:

The United Kingdom respiratory care market, Based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.

List of Conferences:

3rd Rhinology and Otology Conference <br>April 25-27, 2016 Dubai, UAE

4th Bacteriology and Infectious Diseases Conference <br>May 16-18, 2016 San Antonio, USA

2nd Respiratory and Pulmonary Medicine Conference <br>May 09-10, 2016 Chicago, USA

3rd COPD conference <br>July 11-12, 2016 Brisbane, Australia  

2nd Infectious Diseases Conference: <br>August 25-27, 2016 Philadelphia, USA

Global Influenza Conferences <br>August 24-26, 2015 West Drayton, London, UK  

4th Lung and Respiratory Care Conference <br>Aug-1-3, 2016 Manchester, UK

4th Immunology Conference <br>September 28-30, 2015 Houston, Texas, USA

 Infectious Diseases and Diagnostic Microbiology Conference <br>Oct 3-5, 2016 Vancouver, Canada

2nd Flu Conference <br>November 17-19, 2016 San Francisco, USA

Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.

11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India

CHEST 2015 Conference:
October 24-28, Canada

46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015

20th Congress of the Asia Pacific Society of Respirology, Malaysia,
Dec-2-3, 2015

5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney

Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore

Respiratory Diseases Conference:
Sep3-6, Guiyang City

Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel

16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA

European Respiratory Society International Congress:
26 September 2015, Amsterdam 

Relevant Societies and Associations:

Cambridge Development Initiative

Cambridge Graduate Course in Medicine Society

Cambridge Romanian Society

Research Drones Society, Oxford

Midland Geotechnical Society – UK

Palaeontological Association – UK

The British Hospitality Association

National Housing Federation

Self-Storage Association UK

Vietnam Respiratory Society  

Lung Health UK

British Lung Foundation

British Thoracic Society

British Association for Lung Research

The Sarcoidosis charity

The Freeman Heart & Lung Transplant Association

British Snoring and Sleep Apnoea Association

Association of Respiratory Nurses (ARNS)

Association of charted Physiotherapists in respiratory care (ACPRC)

List of Companies and retreat centers:

GlaxoSmithKline

 Pfizer

 Sanofi-Aventis

 AstraZeneca

 Novartis

Roche

 Wyeth

 Merk & Co

 Lilly

 Boehringer Ingelheim

 Johnson & Johnson

 Schering Plough

 Novo Nordisk

 Bayer Schering

 Abbott

 Teva

 Bristol-Myers Squibb

 Mundi Int

 Gilead Sciences

Servier

Edwards Lifesciences

British American Tobacco

Imperial Tobacco Group

Reckitt Benckiser Group

Acm Global Central Laboratory Services Ltd

Acorn Polymers (U K ) Ltd

Access Health Products

Acm Global Central Laboratory Services Ltd

Acorn Equipment Co Ltd

Advanced Healthcare Ltd 

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising